Corcept Therapeutics

YTD

ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.

CEO

Joseph K. Belanoff

CEOJoseph K. Belanoff

Employees

730

Employees730

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

1998

Founded1998

Employees

730

Employees730

CORT Key Statistics

Market cap

13.11B

Market cap13.11B

Price-Earnings ratio

289.44

Price-Earnings ratio289.44

Dividend yield

—

Dividend yield—

Average volume

776.29K

Average volume776.29K

High today

$122.08

High today$122.08

Low today

$119.28

Low today$119.28

Open price

$121.20

Open price$121.20

Volume

497.00K

Volume497.00K

52 Week high

$126.38

52 Week high$126.38

52 Week low

$28.66

52 Week low$28.66

Stock Snapshot

The current Corcept Therapeutics(CORT) stock price is $121.19, with a market capitalization of 13.11B. The stock trades at a price-to-earnings (P/E) ratio of 289.44.

On 2026-10-12, Corcept Therapeutics(CORT) stock moved within a range of $119.28 to $122.08. With shares now at $121.19, the stock is trading +1.6% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 497K, compared to an average daily volume of 776.29K.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $126.38 and a low of $28.66.

CORT News

Reuters 9h

Drugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case - Reuters

...

Simply Wall St 5d

Corcept Therapeutics Earnings And Pipeline Buzz Put Fair Value Back In Focus

Corcept Therapeutics (CORT) is back in focus after the firm paired recent earnings momentum and product pipeline optimism with an executive shakeup in its Endoc...

Investor's Business Daily 6d

Corcept, IBD Stock Of The Day, Setting Up Amid Booming Earnings Growth

Why Former Highflier Corcept Therapeutics Just Surged Again 1/22/2026 Corcept Therapeutics shares jumped Thursday after the company said its drug cut the risk...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

14.3%

Sell

14.3%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Broadcom

Palantir Technologies

Robinhood Markets

Novo Nordisk

Palo Alto Networks

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.